Ageing & Movement Research Group

The Ageing and Movement Research Group is a dynamic, multidisciplinary research collaboration, focused on ageing and movement disorders.

‌‌The AMRG run a portfolio of studies in older adults with a focus on Parkinson's. This includes the £2.1 million CHIEF-PD trial that seeks to evaluate whether cognitive enhancement with rivastigmine prevents falls, and the £10 million PRIME Parkinson programme that innovates care in Parkinson's. We also have an educational workstream that innovates teaching methods in geriatric medicine. 

Read more about our work and team on our website.

Latest publications

Our work

Edit this page